Literature DB >> 22941331

Frequent silencing of protocadherin 8 by promoter methylation, a candidate tumor suppressor for human gastric cancer.

Danjie Zhang1, Wei Zhao, Xinhua Liao, Tieqiang Bi, Haijun Li, Xiangming Che.   

Abstract

The cadherins are a family of cell surface glycoproteins responsible for cell adhesion which play an important role in cell morphology, contact inhibition and signal transduction during tumorigenesis. Protocadherin 8 (PCDH8), a member of the cadherin family, has been reported to act as a tumor suppressor involved in oncogenesis in breast cancer. In this study, we aimed to investigate the epigenetic inactivation of PCDH8 and its tumor suppressor function in gastric cancer. The expression of PCDH8 was markedly reduced or silenced in gastric cancer cell lines compared with normal gastric cells or tissues. Methylation of the PCDH8 gene promoter was observed in 100% (4/4) of cell lines and 55.38% (36/65) of the primary gastric cancer by methylation-specific PCR, but not in normal gastric mucosa (0/10). Methylated PCDH8 was significantly associated with lymph node metastasis in a logistic regression analysis. The demethylation reagent 5-aza-2'-deoxycytidine was able to restore or upregulate PCDH8 expression in gastric cancer cell lines. Ectopic expression of PCDH8 in silenced gastric cancer cells significantly inhibited cell migration and induced apoptosis. For the first time, our study demonstrates the epigenetic inactivation of PCDH8 by promoter methylation and its tumor suppressor function in human gastric cancer. Thus, PCDH8 could be identified as a candidate tumor suppressor in human gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22941331     DOI: 10.3892/or.2012.1997

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

1.  miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.

Authors:  Jianfei Xue; Aidong Zhou; Yamei Wu; Saint-Aaron Morris; Kangyu Lin; Samirkumar Amin; Roeland Verhaak; Gregory Fuller; Keping Xie; Amy B Heimberger; Suyun Huang
Journal:  Cancer Res       Date:  2016-05-31       Impact factor: 12.701

2.  MetaKTSP: a meta-analytic top scoring pair method for robust cross-study validation of omics prediction analysis.

Authors:  SungHwan Kim; Chien-Wei Lin; George C Tseng
Journal:  Bioinformatics       Date:  2016-03-02       Impact factor: 6.937

3.  Association between protocadherin 8 promoter hypermethylation and the pathological status of prostate cancer.

Authors:  Peng Zhang; Hui Wang; Jianming Wang; Qingzuo Liu; Yongqiang Wang; Fan Feng; Lei Shi
Journal:  Oncol Lett       Date:  2017-05-31       Impact factor: 2.967

Review 4.  Aberrant expression and functions of protocadherins in human malignant tumors.

Authors:  Ming Shan; Yonghui Su; Wenli Kang; Ruixin Gao; Xiaobo Li; Guoqiang Zhang
Journal:  Tumour Biol       Date:  2016-07-24

5.  Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project.

Authors:  Christopher J Ricketts; Victoria K Hill; W Marston Linehan
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

6.  Aberrant methylation of PCDH8 is a potential prognostic biomarker for patients with clear cell renal cell carcinoma.

Authors:  Ying-Li Lin; Yan-Ling Wang; Xing-Li Fu; Jian-Guo Ma
Journal:  Med Sci Monit       Date:  2014-11-22

7.  Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.

Authors:  Ying-Li Lin; Yan-Ling Wang; Jian-Guo Ma; Wen-Ping Li
Journal:  J Exp Clin Cancer Res       Date:  2014-08-22

8.  PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance.

Authors:  Cheng Zhang; Yunfei Peng; Fan Yang; Ruixi Qin; Wenjun Liu; Cuijuan Zhang
Journal:  J Cancer       Date:  2016-01-29       Impact factor: 4.207

9.  Aberrant methylation of protocadherin 17 and its clinical significance in patients with prostate cancer after radical prostatectomy.

Authors:  Ying-Li Lin; Pei-Gen Xie; Li Wang; Jian-Guo Ma
Journal:  Med Sci Monit       Date:  2014-08-05

10.  Promoter methylation of protocadherin8 is an independent prognostic factor for biochemical recurrence of early-stage prostate cancer.

Authors:  Wen-Bin Niu; Shi-Liang Gui; Ying-Li Lin; Xing-Li Fu; Jian-Guo Ma; Wen-Ping Li
Journal:  Med Sci Monit       Date:  2014-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.